Cologne, Germany

Stefan Boehm

This inventor holds 1 USPTO granted patent. Top assignee: Cytopharm, Inc.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Boehm. Retrieved from https://idiyas.com/inventor/stefan-boehm-lyod6gf8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Boehm

Introduction

Stefan Boehm is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of photodynamic therapy through his innovative research and development. His work focuses on acetylene-cumulene porphycene compounds, which have promising applications in medical treatments.

Latest Patents

Stefan Boehm holds 1 patent for his invention titled "Acetylene-cumulene porphycene compounds for photodynamic therapy." This patent describes dihydro- and tetrahydro-acetylene-cumulene porphycene compounds that are useful as photodynamic therapy agents. The compounds have a unique structure that enhances their effectiveness in medical applications.

Career Highlights

Stefan Boehm is currently associated with Cytopharm, Inc., where he continues to advance his research in photodynamic therapy. His work has garnered attention for its potential to improve treatment outcomes for various medical conditions.

Collaborations

Stefan collaborates with esteemed colleagues, including Emanuel Vogel and Alexander D Cross. Their combined expertise contributes to the innovative research environment at Cytopharm, Inc.

Conclusion

Stefan Boehm's contributions to the field of photodynamic therapy through his patented inventions highlight his role as a significant innovator in medical research. His work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…